Use of γ-inulin/liposomes/Vitamin E adjuvant combination in contraceptive vaccines

International Journal of Pharmaceutics

Volumn 257, Issue 1-2, 2003, Pages 85-95

  Fuentes, P ^a   Cooper, P D ^b   Barnadas, R ^a   Sabes M ^a   Osterhoff, C ^c   Martinez P ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Australian National University   (Australia)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Contraception; Freund's adjuvant; Gamma inulin; HE2 sperm antigen; Liposomes; Vitamin E

Indexed keywords

CONTRACEPTIVE VACCINE; FREUND ADJUVANT; GAMMA INULIN; INULIN; LIPOSOME; SPERM ANTIGEN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DISTRESS SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; SPERM;

EID: 0344950492     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00127-3     Document Type: Article

References (29)

1. Barnadas R., Campillo M., Sabés M. Liposome size determination using a Microtrack UPA. Eur. Biophys. J. 26:1997;128.
2. Benet-Rubinat J.M., Martínez P., Lepp W.A., Andolz P., Bielsa M.A., Egozcue J. Detection of induced anti-sperm antibodies by an improved Enzyme-Linked Immunosorbent Assay. Int. J. Fertil. 36:1991;48-56.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Broderson J.R. A retrospective review of lesions associated with the use of Freund's adjuvant. Lab. Anim. Sci. 39:1989;400-405.
5. Chapel H.M., August P.J. Report on nine cases of accidental injury to man with Freund's complete adjuvants. Clin. Exp. Immunol. 24:1976;538-541.
6. Cooper, P.D., 1995. Vaccine adjuvants based on gamma inulin. In: Powell, M.F., Newman, M.J. (Eds.), Vaccine Design: The Subunit and Adjuvant Approach. Plenum Press, New York, pp. 559-580.
7. Cooper P.D., Carter M. Anticomplementary action of polymorphic 'solubility forms' of particulate inulin. Mol. Immunol. 23:1986;895-901.
8. Cooper P.D., Steele E.J. The adjuvanticity of gamma inulin. Immunol. Cell Biol. 66:1988;345-352.
9. Cooper P.D., Turner R., McGovern J. Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice. Immunol. Lett. 27:1991;131-134.
10. Cullis, P.R., Hope, M.J., Bally, M.B., Madden, T.D., Mayer, L,D., Janoff, A.S., 1987. Liposomes as pharmaceuticals. In: Liposomes from Biophysics to Therapeutics. Marcel Dekker, New York, 39 pp.
11. Deol H.S., Palmer D.G., Dunsmore T., Carnegie P.R. The influence of gamma inulin and Algammulin on the immune response in sheep to a recombinant antigen of Taenia ovis. Vaccine. 13:1995;429-433.
12. Diekman A.B., Herr J.C. Sperm antigens and their use in development of an immunocontraceptive. Am. J. Reprod. Immunol. 37:1997;111-117.
13. Fuentes P., Martínez P. Passive immunization with antisperm monoclonal antibody ZAP-7 increases preimplantation embryo mortality in the mouse. Fertil. Steril. 73:2000;1126-1131.
14. Herr J.C. Update on the center for recombinant gamete contraceptive vaccinogen. Am. J. Reprod. Immunol. 35:1996;184-189.
15. Hunter D.D., Porter B.E., Bulock J.W., Adams S.P., Merlie J.P., Sanes J.R. Primary sequence of a motor-neuron selective adhesive site in the synaptic basal lamina proteins-laminin. Cell. 59:1989;905-913.
16. Johnson S.M., Baugham A.D., Hill H.W., Korn E.D. Single bilayer liposomes. Biochim. Biophys. Acta. 233:1971;820.
17. Jones L.J., Spencer L., Lord R., Saul A.J. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2. Vaccine. 14:1996;77-84.
18. Kahn J.O., Stites D.P., Scillian J., Murcar N., Stryker R.et al. A Phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue subunit vaccine in seronegative subjects. AIDS Res. Hum. Retrovirus. 8:1992;1321-1325.
19. Kerekes K., Cooper P.D., Prechl J., Jozsi M., Bajtay Z., Erdei A. Adjuvant effect of gamma-inulin is mediated by C3 fragments deposited on antigen-presenting cells. J. Leukoc. Biol. 69:2001;69-74.
20. Laemli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 217:1970;680-685.
21. Lasic, D.D., 1993. Liposomes, from Physics to Application. Elsevier Publishers, Amsterdam.
22. Lepp W.A., Martínez P. Solid-phase-enzyme immunoassay for the detection of HMG nonhistone proteins in their native structure. J. Immunoassay. 10:1989;449-465.
23. Morton D.B., Griffiths P.H.M. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet. Record. 116:1985;431-436.
24. Naylor P.H., Sztein M.B., Wada S., Maurer S., Holterman D.et al. Preclinical and clinical studies on immunogenicity vaccine HGP-30-KLH. Int. J. Immunopharmacol. 13:1991;117-127.
25. Odeleye O.E., Eskelson C.D., Mufti S.I., Watson R.R. Vitamin E protection against chemically-induced esophageal tumor growth in mice immunocompromised by retroviral infection. Carcinogenesis. 13:1992;1811-1816.
26. Osterhoff C., Kirchhoff C., Krull N., Ivell R. Molecular cloning and characterization of a novel human sperm antigen (HE2) specifically expressed in the proximal epididymis. Biol. Reprod. 50:1994;516-525.
27. Toth L.A., Dunlap A.W., Olson G.A., Hessler J.R. An evaluation of distress following intraperitoneal immunization with Freund's adjuvant in mice. Lab. Anim. Sci. 32:1989;122-126.
28. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
29. Wang J.Y., Liang B., Watson R.R. Vitamin E supplementation with interferon-γ administration retards immune dysfunction during murine retrovirus infection. J. Leukocyte Biol. 58:1995;698-703.